Filing Details

Accession Number:
0001363213-12-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-08 12:47:45
Reporting Period:
2012-05-31
Filing Date:
2012-06-08
Accepted Time:
2012-06-08 12:47:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363213 Friedhelm Blobel 950 Tower Lane, Suite 900
Foster City CA 94404
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-31 1,000 $3.84 47,018 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Acquisiton 2012-06-07 100,000 $0.00 100,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
196,052 No 4 A Direct
Footnotes
  1. Purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2012.
  2. Granted under the Issuer's 2005 Equity Incentive Plan.
  3. Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
  4. 100% of the restricted stock units will vest on February 25, 2014, unless the trading window is closed for the Reporting Person on that date, then the vesting date will be deferred until the next date that the trading window is open.